CYTK
CYTOKINETICS INC
NASDAQ · Healthcare · Biotechnology · US
$63.60
+2.07%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 24.64x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -50.97x
- Price / sales
- 124.60x
- Price / cash flow
- -15.92x
Enterprise value
- Enterprise value
- $8.9B
- EV / sales
- 126.08x
- EV / EBITDA
- -10.89x
- EV / EBIT
- -12.70x
- Market cap
- $8.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026